Valuation: TransMedics Group, Inc.

Capitalization 4.6B 3.94B 3.66B 3.42B 6.38B 415B 6.85B 42.22B 16.59B 198B 17.26B 16.9B 728B P/E ratio 2025 *
51.9x
P/E ratio 2026 * 48.9x
Enterprise value 4.67B 4B 3.72B 3.47B 6.48B 421B 6.95B 42.84B 16.84B 201B 17.51B 17.15B 738B EV / Sales 2025 *
7.77x
EV / Sales 2026 * 6.31x
Free-Float
96.82%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.76%
1 week+6.64%
Current month+10.69%
1 month+6.21%
3 months+25.51%
6 months+19.74%
Current year+10.69%
More quotes
1 week 131
Extreme 131
141.89
1 month 119.29
Extreme 119.29
141.89
Current year 120.17
Extreme 120.171
141.89
1 year 55
Extreme 55
156
3 years 36.42
Extreme 36.4201
177.37
5 years 10
Extreme 10
177.37
10 years 10
Extreme 10
177.37
More quotes
Manager TitleAgeSince
Chief Executive Officer 57 1998-07-31
Director of Finance/CFO 55 2024-12-01
Chief Operating Officer 43 2023-02-01
Director TitleAgeSince
Director/Board Member 57 1998-07-31
Chairman 81 2010-12-31
Director/Board Member 78 2016-01-31
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.76%+6.64%+95.70%+125.86% 4.6B
-0.55%+0.70%+13.49%+5.83% 231B
-2.30%+1.12%+4.62%+122.91% 203B
+0.26%+1.55%+1.67%-12.23% 169B
-1.97%+0.25%+0.89%+104.92% 142B
+0.99%+4.61%-7.43%-4.22% 61.2B
-2.49%-1.38%+13.06%+6.77% 48.17B
-0.36%+3.54%+7.65%-5.43% 41.95B
-0.44%+2.19%+2.52%+32.37% 39.58B
+2.13%+5.09%+10.27%+20.49% 37.56B
Average -0.97%+2.43%+14.24%+39.73% 97.81B
Weighted average by Cap. -1.02%+1.39%+6.02%+42.53%
See all sector performances

Financials

2025 *2026 *
Net sales 601M 515M 478M 446M 834M 54.16B 894M 5.51B 2.17B 25.91B 2.25B 2.21B 95B 725M 621M 577M 538M 1.01B 65.35B 1.08B 6.65B 2.61B 31.26B 2.72B 2.66B 115B
Net income 101M 86.41M 80.36M 74.92M 140M 9.1B 150M 926M 364M 4.35B 378M 371M 15.95B 109M 93.18M 86.65M 80.79M 151M 9.81B 162M 998M 392M 4.69B 408M 400M 17.2B
Net Debt 67.83M 58.09M 54.02M 50.36M 94.1M 6.11B 101M 622M 245M 2.92B 254M 249M 10.72B -26.7M -22.86M -21.26M -19.82M -37.04M -2.41B -39.72M -245M -96.27M -1.15B -100M -98.07M -4.22B
More financial data * Estimated data
Logo TransMedics Group, Inc.
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ retrieval, OCS organ management and logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation, ground transportation and other coordination activity. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Employees
728
More about the company
Date Price Change Volume
26-01-12 134.66 $ -1.76% 580,841
26-01-09 137.07 $ -0.36% 364,281
26-01-08 137.57 $ +0.22% 692,047
26-01-07 137.27 $ +3.47% 732,998
26-01-06 132.67 $ +5.06% 692,887

Delayed Quote Nasdaq, January 12, 2026 at 04:00 pm EST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
134.66USD
Average target price
144.73USD
Spread / Average Target
+7.48%
Consensus

Quarterly revenue - Rate of surprise